Pulmocide announces publication of clinical data in two peer-reviewed publications highlighting potential of PC945, a novel inhaled antifungal drug candidate, in lung infections March 11, 2021
Stephen Elledge’s Harvard lab takes $17M to birth ImmuneID, a high-throughput antibody startup February 18, 2021
Alnylam, founded by Christoph Westphal as CEO, scores European approval for rare disease med Oxlumo November 20, 2020
